Background Neoadjuvant chemotherapy (NAC) has become an essential treatment for
breast cancer. However, there is still no consensus on the best tool to evaluate pathological …

Imaging, including its use for innovative tissue sampling, is slowly being recognized as
playing a pivotal role in drug development, clinical trial design, and more effective delivery …

Introduction. This study compared the diagnostic test accuracy of magnetic resonance
imaging (MRI) with that of 18F-fluoro-2-glucose-positron emission tomography/computed …

Breast cancer is the most common cancer among women in the United States and the
second leading cause of cancer-related deaths; approximately 12.9% of women will be …

OBJECTIVE. The goals of this review are to provide background information on the
definitions and applications of the general term “biomarker” and to highlight the specific …

The success of breast cancer therapy is ultimately defined by clinical endpoints such as
survival. It is valuable to have biomarkers that can predict the most efficacious therapies or …

Simple Summary Artificial intelligence (AI) has seamlessly integrated into the medical field,
especially in diagnostic imaging, thanks to ongoing AI advancements. It is widely used in …

Purpose. We performed this meta‐analysis to determine the utilities of 18F‐FDG PET/CT
and MRI in assessing the pathological complete response (pCR) after neoadjuvant …

Gradually, FDG-PET/CT has been strengthening within the diagnostic algorithms of
oncological diseases. In many of these, PET/CT has shown to be useful at different stages of …

The goals of precision oncology are to provide targeted drug therapy based on each
individual's specific tumor biology, and to enable the prediction and early assessment of …